ARTICLES:

RM Edwards, EJ Stack, EF Weidley, N Aiyar, RM Keenan, DT Hill, and J Weinstock

Characterization of renal angiotensin II receptors using subtype selective antagonists
J Pharmacol Exp Ther 1992 260: 933-938. [Abstract] [PDF]  

CS Boyer and DR Petersen

Enzymatic basis for the transesterification of cocaine in the presence of ethanol: evidence for the participation of microsomal carboxylesterases
J Pharmacol Exp Ther 1992 260: 939-946. [Abstract] [PDF]  

I Knezevic, JP Dieter, and GC Le Breton

Mechanism of inositol 1,4,5-trisphosphate-induced aggregation in saponin-permeabilized platelets
J Pharmacol Exp Ther 1992 260: 947-955. [Abstract] [PDF]  

JA Nathanson

Nitrovasodilators as a new class of ocular hypotensive agents
J Pharmacol Exp Ther 1992 260: 956-965. [Abstract] [PDF]  

L Wu, R Wang, E Karpinski, and PK Pang

Bay K-8644 in different solvents acts as a transient calcium channel antagonist and a long-lasting calcium channel agonist
J Pharmacol Exp Ther 1992 260: 966-973. [Abstract] [PDF]  

K Matsubara, S Fukushima, A Akane, S Kobayashi, and H Shiono

Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4- dihydroxyphenylalanine in humans
J Pharmacol Exp Ther 1992 260: 974-978. [Abstract] [PDF]  

RA Hahn, BR MacDonald, E Morgan, BD Potts, CJ Parli, LE Rinkema, CA Whitesitt, and WS Marshall

Evaluation of LY203647 on cardiovascular leukotriene D4 receptors and myocardial reperfusion injury
J Pharmacol Exp Ther 1992 260: 979-989. [Abstract] [PDF]  

M Klein and JM Musacchio

High-affinity dextromethorphan and (+)-3-(-3-hydroxyphenyl)-N-(1- propyl)piperidine binding sites in rat brain. Allosteric effects of ropizine
J Pharmacol Exp Ther 1992 260: 990-999. [Abstract] [PDF]  

G Olmos, A Miralles, F Barturen, and JA Garcia-Sevilla

Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment
J Pharmacol Exp Ther 1992 260: 1000-1007. [Abstract] [PDF]  

F Chaouloff, SH Gunn, and JB Young

Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5- hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat
J Pharmacol Exp Ther 1992 260: 1008-1016. [Abstract] [PDF]  

KA Grant, LD Snell, MA Rogawski, A Thurkauf, and B Tabakoff

Comparison of the effects of the uncompetitive N-methyl-D-aspartate antagonist (+-)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures
J Pharmacol Exp Ther 1992 260: 1017-1022. [Abstract] [PDF]  

T Shea-Donohue, A Kandasamy, and A Dubois

Effects of a prostacyclin analog, U-68,215, on gastric acid secretion, gastric emptying and systemic blood pressure in primates
J Pharmacol Exp Ther 1992 260: 1023-1027. [Abstract] [PDF]  

H Bergstrand, B Lundquist, K Karabelas, and P Michelsen

Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor
J Pharmacol Exp Ther 1992 260: 1028-1037. [Abstract] [PDF]  

HH Saunders and JM Farley

Pharmacological properties of potassium currents in swine tracheal smooth muscle
J Pharmacol Exp Ther 1992 260: 1038-1044. [Abstract] [PDF]  

CE Ybema, JL Slangen, B Olivier, and J Mos

Discriminative stimulus properties of the serotonergic compound eltoprazine
J Pharmacol Exp Ther 1992 260: 1045-1051. [Abstract] [PDF]  

HK Kroemer, H Echizen, H Heidemann, and M Eichelbaum

Predictability of the in vivo metabolism of verapamil from in vitro data: contribution of individual metabolic pathways and stereoselective aspects
J Pharmacol Exp Ther 1992 260: 1052-1057. [Abstract] [PDF]  

K Miyake, T Taguchi, K Tanonaka, T Horiguchi, N Takagi, and S Takeo

Beneficial effects of naftidrofuryl oxalate on brain regional energy metabolism after microsphere-induced cerebral embolism
J Pharmacol Exp Ther 1992 260: 1058-1066. [Abstract] [PDF]  

J Martinez, MJ Fargeas, and L Bueno

Gastrointestinal motor alterations induced by precipitated benzodiazepine withdrawal in rats
J Pharmacol Exp Ther 1992 260: 1067-1072. [Abstract] [PDF]  

D Stretton, MG Belvisi, and PJ Barnes

The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways
J Pharmacol Exp Ther 1992 260: 1073-1080. [Abstract] [PDF]  

JJ Mosterd and HH Thijssen

The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat
J Pharmacol Exp Ther 1992 260: 1081-1085. [Abstract] [PDF]  

LF Tseng and KA Collins

Cholecystokinin administered intrathecally selectively antagonizes intracerebroventricular beta-endorphin-induced tail-flick inhibition in the mouse
J Pharmacol Exp Ther 1992 260: 1086-1092. [Abstract] [PDF]  

V Serval, T Galli, A Cheramy, J Glowinski, and S Lavielle

In vitro and in vivo inhibition of N-acetyl-L-aspartyl-L-glutamate catabolism by N-acylated L-glutamate analogs
J Pharmacol Exp Ther 1992 260: 1093-1100. [Abstract] [PDF]  

SW Watts and ML Cohen

Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists
J Pharmacol Exp Ther 1992 260: 1101-1106. [Abstract] [PDF]  

WM Armstead, R Mirro, SL Zuckerman, and CW Leffler

Vasopressin modulates cerebrovascular responses to opioids in newborn pigs
J Pharmacol Exp Ther 1992 260: 1107-1112. [Abstract] [PDF]  

S Chakder and S Rattan

Neurally mediated relaxation of opossum internal anal sphincter: influence of superoxide anion generator and the scavenger
J Pharmacol Exp Ther 1992 260: 1113-1118. [Abstract] [PDF]  

H Shimamoto, JP Bourreau, CY Kwan, and EE Daniel

Amplification of alpha adrenergic vasoconstriction in canine isolated mesenteric artery and vein
J Pharmacol Exp Ther 1992 260: 1119-1127. [Abstract] [PDF]  

S Fukuda, M Morioka, T Tanaka, and K Shimoji

Prostaglandin E1-induced vasorelaxation in porcine coronary arteries
J Pharmacol Exp Ther 1992 260: 1128-1132. [Abstract] [PDF]  

R Martino, F Crasnier, N Chouini-Lalanne, V Gilard, U Niemeyer, M De Forni, and MC Malet-Martino

A new approach to the study of ifosfamide metabolism by the analysis of human body fluids with 31P nuclear magnetic resonance spectroscopy
J Pharmacol Exp Ther 1992 260: 1133-1144. [Abstract] [PDF]  

DL Willins, LJ Wallace, DD Miller, and NJ Uretsky

alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drugs
J Pharmacol Exp Ther 1992 260: 1145-1151. [Abstract] [PDF]  

C Soulard, X Pascaud, FJ Roman, A Grouhel, and JL Junien

Pharmacological evaluation of JO 1870: relation to the potential treatment of urinary bladder incontinence
J Pharmacol Exp Ther 1992 260: 1152-1158. [Abstract] [PDF]  

N Yoshida, H Omoya, and T Ito

DAT-582, a novel serotonin3 receptor antagonist, is a potent and long- lasting antiemetic agent in the ferret and dog
J Pharmacol Exp Ther 1992 260: 1159-1165. [Abstract] [PDF]  

J Magdalou, R Herber, R Bidault, and G Siest

In vitro N-glucuronidation of a novel antiepileptic drug, lamotrigine, by human liver microsomes
J Pharmacol Exp Ther 1992 260: 1166-1173. [Abstract] [PDF]  

EJ Cline, U Scheffel, JW Boja, FI Carroll, JL Katz, and MJ Kuhar

Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency
J Pharmacol Exp Ther 1992 260: 1174-1179. [Abstract] [PDF]  

MS Kannan and DE Johnson

Functional innervation of pig tracheal smooth muscle: neural and non- neural mechanisms of relaxation
J Pharmacol Exp Ther 1992 260: 1180-1184. [Abstract] [PDF]  

NK Mello, SE Lukas, JB Kamien, JH Mendelson, J Drieze, and EJ Cone

The effects of chronic buprenorphine treatment on cocaine and food self- administration by rhesus monkeys
J Pharmacol Exp Ther 1992 260: 1185-1193. [Abstract] [PDF]  

AM Bendele, KJ Ruterbories, SM Spaethe, DN Benslay, TD Lindstrom, SJ Lee, and RW Naismith

Correlation of anti-inflammatory activity with peak tissue rather than peak plasma levels of BF389
J Pharmacol Exp Ther 1992 260: 1194-1198. [Abstract] [PDF]  

RR Griffiths, CA Sannerud, NA Ator, and JV Brady

Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal
J Pharmacol Exp Ther 1992 260: 1199-1208. [Abstract] [PDF]  

I Oye, O Paulsen, and A Maurset

Effects of ketamine on sensory perception: evidence for a role of N- methyl-D-aspartate receptors
J Pharmacol Exp Ther 1992 260: 1209-1213. [Abstract] [PDF]  

AE Sabouraud, M Urtizberea, NJ Cano, M Grandgeorge, JM Rouzioux, and JM Scherrmann

Colchicine-specific Fab fragments alter colchicine disposition in rabbits
J Pharmacol Exp Ther 1992 260: 1214-1219. [Abstract] [PDF]  

GD Lopaschuk, R Barr, and R Wambolt

Effects of diltiazem on glycolysis and oxidative metabolism in the ischemic and ischemic/reperfused heart
J Pharmacol Exp Ther 1992 260: 1220-1228. [Abstract] [PDF]  

XL Ma, AS Weyrich, S Krantz, and AM Lefer

Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion
J Pharmacol Exp Ther 1992 260: 1229-1236. [Abstract] [PDF]  

P Horan, J Taylor, HI Yamamura, and F Porreca

Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor- BNI) in the mouse tail-flick test
J Pharmacol Exp Ther 1992 260: 1237-1243. [Abstract] [PDF]  

KC Malcolm and FA Fitzpatrick

Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways
J Pharmacol Exp Ther 1992 260: 1244-1249. [Abstract] [PDF]  

IM Dauber, EJ Lesnefsky, RC Ashmore, DM Martel, FM Sheridan, JV Weil, and LD Horwitz

Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline
J Pharmacol Exp Ther 1992 260: 1250-1256. [Abstract] [PDF]  

S Ahmad, L Wang, and PE Ward

Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo
J Pharmacol Exp Ther 1992 260: 1257-1261. [Abstract] [PDF]  

M Okumura, K Miura, Y Yamashita, T Yukimura, and K Yamamoto

Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs
J Pharmacol Exp Ther 1992 260: 1262-1267. [Abstract] [PDF]  

JW Hubbard, KW Locke, HV Forster, AG Brice, LG Pan, TF Lowry, AM Forster, MA Forster, M Cornfeldt, and CL Vanselous

Cardiorespiratory effects of the novel opioid analgesic HP 736 in the anesthetized dog and conscious goat
J Pharmacol Exp Ther 1992 260: 1268-1277. [Abstract] [PDF]  

CG Craig and TD White

Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate- mediated neurotransmission in the cortex
J Pharmacol Exp Ther 1992 260: 1278-1284. [Abstract] [PDF]  

SG Matta and BM Sharp

The role of the fourth cerebroventricle in nicotine-stimulated prolactin release in the rat: involvement of catecholamines
J Pharmacol Exp Ther 1992 260: 1285-1291. [Abstract] [PDF]  

JC Shryock, HC Travagli, and L Belardinelli

Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart
J Pharmacol Exp Ther 1992 260: 1292-1299. [Abstract] [PDF]  

M Masuo, T Shimada, and T Kitazawa

Mechanism of inhibitory effects of azelastine on smooth muscle contraction
J Pharmacol Exp Ther 1992 260: 1300-1308. [Abstract] [PDF]  

T Katsuragi, O Soejima, T Tokunaga, and T Furukawa

Evidence for postjunctional release of ATP evoked by stimulation of muscarinic receptors in ileal longitudinal muscles of guinea pig
J Pharmacol Exp Ther 1992 260: 1309-1313. [Abstract] [PDF]  

GT Bolger, R Berry, F Liard, M Garneau, and J Jaramillo

Cardiac responses and binding sites for endothelin in normal and cardiomyopathic hamsters
J Pharmacol Exp Ther 1992 260: 1314-1322. [Abstract] [PDF]  

K Mubagwa, AM Vites, and AJ Pappano

Stimulant effects of muscarinic agonists in embryonic chick ventricular muscle. Are the effects mediated by protein kinase C?
J Pharmacol Exp Ther 1992 260: 1323-1330. [Abstract] [PDF]  

TM Guenthner, R Whalen, and V Jevtovic-Todorovic

Direct measurement of melphalan conjugation with glutathione: studies with human melanoma cells and mammalian liver
J Pharmacol Exp Ther 1992 260: 1331-1336. [Abstract] [PDF]  

JB 3d Watkins and SE Sherman

Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin
J Pharmacol Exp Ther 1992 260: 1337-1343. [Abstract] [PDF]  

N Murakami, J Fukata, T Usui, Y Naito, T Tominaga, Y Nakai, Y Masui, K Nakao, and H Imura

Effects of repetitive administration of recombinant human interleukin-1 beta, an analog or corticotropin-releasing hormone combined with lysine vasopressin on rats with glucocorticoid-induced secondary adrenocortical insufficiency
J Pharmacol Exp Ther 1992 260: 1344-1348. [Abstract] [PDF]  

M Polhuijs, AC Tergau, and GJ Mulder

Chiral inversion and stereoselective glutathione conjugation of the four 2-bromo-3-methylvaleric acid stereoisomers in the rat in vivo and in vitro
J Pharmacol Exp Ther 1992 260: 1349-1354. [Abstract] [PDF]  

V Fischer, B Vogels, G Maurer, and RE Tynes

The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6
J Pharmacol Exp Ther 1992 260: 1355-1360. [Abstract] [PDF]  

BL Roth, RD Ciaranello, and HY Meltzer

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors
J Pharmacol Exp Ther 1992 260: 1361-1365. [Abstract] [PDF]  

M Stokke, EM Hagelin, C Poulsson, R Patel, Y Haile, and O Brors

Inhibition by amiloride and quinacrine of specific [3H]nitrendipine binding to rat cardiac membranes
J Pharmacol Exp Ther 1992 260: 1366-1372. [Abstract] [PDF]  

A Souque, C Gros, and JC Schwartz

Binding of [125I]atrial natriuretic factor to mouse lung membranes in vivo: characterization and effects of peptidase inhibitors
J Pharmacol Exp Ther 1992 260: 1373-1378. [Abstract] [PDF]  

FN Quandt and WB Im

Tetraalkylammonium ion block of potassium currents in mouse neuroblastoma cells
J Pharmacol Exp Ther 1992 260: 1379-1385. [Abstract] [PDF]  

Y Hiraoka, C Kishimoto, M Kurokawa, H Ochiai, and S Sasayama

The effects of FK-506, a novel and potent immunosuppressant, upon murine Coxsackievirus B3 myocarditis
J Pharmacol Exp Ther 1992 260: 1386-1391. [Abstract] [PDF]  

GJ Brunn, DE Keyler, SM Pond, and PR Pentel

Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate
J Pharmacol Exp Ther 1992 260: 1392-1399. [Abstract] [PDF]  

MS Saporito, RE Heikkila, SK Youngster, WJ Nicklas, and HM Geller

Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration
J Pharmacol Exp Ther 1992 260: 1400-1409. [Abstract] [PDF]  

CT Jr Stier, K Mahboubi, VA DiPippo, S Levine, and PN Chander

The antiproteinuric action of enalapril in stroke-prone spontaneously hypertensive rats is unrelated to alterations in urinary prostaglandins
J Pharmacol Exp Ther 1992 260: 1410-1415. [Abstract] [PDF]  

LM Fleming, G Ponjee, and SR Childers

Inhibition of protein phosphorylation by opioid-inhibited adenylyl cyclase in rat brain membranes
J Pharmacol Exp Ther 1992 260: 1416-1424. [Abstract] [PDF]  

JB Long, DD Rigamonti, K Dosaka, JM Kraimer, and A Martinez-Arizala

Somatostatin causes vasoconstriction, reduces blood flow and increases vascular permeability in the rat central nervous system
J Pharmacol Exp Ther 1992 260: 1425-1432. [Abstract] [PDF]  

P Branchereau, GA Bohme, J Champagnat, MP Morin-Surun, C Durieux, JC Blanchard, BP Roques, and M Denavit-Saubie

CholecystokininA and cholecystokininB receptors in neurons of the brainstem solitary complex of the rat: pharmacological identification
J Pharmacol Exp Ther 1992 260: 1433-1440. [Abstract] [PDF]  

T Chang, M Levine, SM Bandiera, and GD Bellward

Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine
J Pharmacol Exp Ther 1992 260: 1441-1449. [Abstract] [PDF]  

T Chang, M Levine, and GD Bellward

Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine
J Pharmacol Exp Ther 1992 260: 1450-1455. [Abstract] [PDF]  

ERRATUM
J Pharmacol Exp Ther 1992 260: 1456. [Abstract] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.